Answers are grounded in this paper and cite their sources.
The Third Cambridge Conference on Novel Agents in the Treatment of Lung Cancer was convened in Cambridge, Massachusetts on September 23 to 24, 2005 to discuss ongoing research into the significance of the epidermal growth factor receptor (EGFR) pathway in the biology of non–small cell lung cancer
No takes yet. Share an insight, caveat, or question.
Lynch et al. (2006) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: